Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

1.

Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases.

Rick FG, Schally AV, Szalontay L, Block NL, Szepeshazi K, Nadji M, Zarandi M, Hohla F, Buchholz S, Seitz S.

Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):1655-60. doi: 10.1073/pnas.1120588109. Epub 2012 Jan 18.

PMID:
22307626
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Inhibitory effects of antagonists of growth hormone-releasing hormone on growth and invasiveness of PC3 human prostate cancer.

Muñoz-Moreno L, Arenas MI, Schally AV, Fernández-Martínez AB, Zarka E, González-Santander M, Carmena MJ, Vacas E, Prieto JC, Bajo AM.

Int J Cancer. 2013 Feb 15;132(4):755-65. doi: 10.1002/ijc.27716. Epub 2012 Jul 27.

PMID:
22777643
[PubMed - indexed for MEDLINE]
3.

Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia.

Rick FG, Schally AV, Block NL, Nadji M, Szepeshazi K, Zarandi M, Vidaurre I, Perez R, Halmos G, Szalontay L.

Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3755-60. doi: 10.1073/pnas.1018086108. Epub 2011 Feb 14.

PMID:
21321192
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138.

Heinrich E, Schally AV, Buchholz S, Rick FG, Halmos G, Mile M, Groot K, Hohla F, Zarandi M, Varga JL.

Prostate. 2008 Dec 1;68(16):1763-72. doi: 10.1002/pros.20843.

PMID:
18729085
[PubMed - indexed for MEDLINE]
5.

Antiproliferative effect of growth hormone-releasing hormone (GHRH) antagonist on ovarian cancer cells through the EGFR-Akt pathway.

Guo J, Schally AV, Zarandi M, Varga J, Leung PC.

Reprod Biol Endocrinol. 2010 May 28;8:54. doi: 10.1186/1477-7827-8-54.

PMID:
20509930
[PubMed - indexed for MEDLINE]
Free PMC Article
6.
7.

Preclinical efficacy of growth hormone-releasing hormone antagonists for androgen-dependent and castration-resistant human prostate cancer.

Fahrenholtz CD, Rick FG, Garcia MI, Zarandi M, Cai RZ, Block NL, Schally AV, Burnstein KL.

Proc Natl Acad Sci U S A. 2014 Jan 21;111(3):1084-9. doi: 10.1073/pnas.1323102111. Epub 2014 Jan 6.

PMID:
24395797
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Inhibitory effect of antagonists of bombesin and growth hormone-releasing hormone on orthotopic and intraosseous growth and invasiveness of PC-3 human prostate cancer in nude mice.

Stangelberger A, Schally AV, Varga JL, Zarandi M, Szepeshazi K, Armatis P, Halmos G.

Clin Cancer Res. 2005 Jan 1;11(1):49-57.

PMID:
15671527
[PubMed - indexed for MEDLINE]
Free Article
9.

Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers.

Seitz S, Rick FG, Schally AV, Treszl A, Hohla F, Szalontay L, Zarandi M, Ortmann O, Engel JB, Buchholz S.

Oncol Rep. 2013 Jul;30(1):413-8. doi: 10.3892/or.2013.2435. Epub 2013 Apr 29.

PMID:
23624870
[PubMed - indexed for MEDLINE]
10.

Growth hormone-releasing hormone antagonists inhibit growth of human ovarian cancer.

Papadia A, Schally AV, Halmos G, Varga JL, Seitz S, Buchholz S, Rick F, Zarandi M, Bellyei S, Treszl A, Szalontay L, Lucci JA.

Horm Metab Res. 2011 Oct;43(11):816-20. doi: 10.1055/s-0031-1287766. Epub 2011 Oct 18.

PMID:
22009378
[PubMed - indexed for MEDLINE]
11.

Antioxidant activity of growth hormone-releasing hormone antagonists in LNCaP human prostate cancer line.

Barabutis N, Schally AV.

Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20470-5. doi: 10.1073/pnas.0811209106. Epub 2008 Dec 15.

PMID:
19075233
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Antagonists of growth hormone-releasing hormone inhibit the proliferation of human benign prostatic hyperplasia cells.

Siejka A, Schally AV, Block NL, Barabutis N.

Prostate. 2010 Jul 1;70(10):1087-93. doi: 10.1002/pros.21142.

PMID:
20232355
[PubMed - indexed for MEDLINE]
13.

The combination of antagonists of LHRH with antagonists of GHRH improves inhibition of androgen sensitive MDA-PCa-2b and LuCaP-35 prostate cancers.

Stangelberger A, Schally AV, Zarandi M, Heinrich E, Groot K, Havt A, Kanashiro CA, Varga JL, Halmos G.

Prostate. 2007 Sep 1;67(12):1339-53.

PMID:
17624923
[PubMed - indexed for MEDLINE]
14.

The effect of GHRH antagonists on human glioblastomas and their mechanism of action.

Pozsgai E, Schally AV, Zarandi M, Varga JL, Vidaurre I, Bellyei S.

Int J Cancer. 2010 Nov 15;127(10):2313-22. doi: 10.1002/ijc.25259.

PMID:
20162575
[PubMed - indexed for MEDLINE]
15.

Growth hormone-releasing hormone antagonist induces apoptosis of human endometrial cancer cells through PKCδ-mediated activation of p53/p21.

Wu HM, Schally AV, Cheng JC, Zarandi M, Varga J, Leung PC.

Cancer Lett. 2010 Dec 1;298(1):16-25. doi: 10.1016/j.canlet.2010.05.022. Epub 2010 Jul 13.

PMID:
20630651
[PubMed - indexed for MEDLINE]
16.

GHRH antagonist causes DNA damage leading to p21 mediated cell cycle arrest and apoptosis in human colon cancer cells.

Hohla F, Buchholz S, Schally AV, Seitz S, Rick FG, Szalontay L, Varga JL, Zarandi M, Halmos G, Vidaurre I, Krishan A, Kurtoglu M, Chandna S, Aigner E, Datz C.

Cell Cycle. 2009 Oct 1;8(19):3149-56. Epub 2009 Oct 3.

PMID:
19755849
[PubMed - indexed for MEDLINE]
Free Article
17.

Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways.

Plonowski A, Schally AV, Varga JL, Rekasi Z, Hebert F, Halmos G, Groot K.

Prostate. 2000 Jul 1;44(2):172-80.

PMID:
10881027
[PubMed - indexed for MEDLINE]
18.

Growth hormone-releasing hormone (GHRH) antagonists inhibit the proliferation of androgen-dependent and -independent prostate cancers.

Letsch M, Schally AV, Busto R, Bajo AM, Varga JL.

Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1250-5. Epub 2003 Jan 21.

PMID:
12538852
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Cellular mechanisms of growth inhibition of human endometrial cancer cell line by an antagonist of growth hormone-releasing hormone.

Zhao L, Yano T, Osuga Y, Nakagawa S, Oishi H, Wada-Hiraike O, Tang X, Yano N, Kugu K, Schally AV, Taketani Y.

Int J Oncol. 2008 Mar;32(3):593-601.

PMID:
18292936
[PubMed - indexed for MEDLINE]
20.

Inhibitory effects of antagonists of growth hormone releasing hormone on experimental prostate cancers are associated with upregulation of wild-type p53 and decrease in p21 and mutant p53 proteins.

Stangelberger A, Schally AV, Rick FG, Varga JL, Baker B, Zarandi M, Halmos G.

Prostate. 2012 Apr;72(5):555-65. doi: 10.1002/pros.21458. Epub 2011 Jul 27.

PMID:
21796649
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk